Parkinsonism & Related Disorders
Volume 16, Issue 4 , Pages 252-255 , May 2010

Cardiac 123I-MIBG uptake is reduced more markedly in patients with REM sleep behavior disorder than in those with early stage Parkinson's disease

  • Kenichi Kashihara

      Affiliations

    • Department of Neurology, Okayama Kyokuto Hospital, 567-1 Kurata, Naka-ku, Okayama 703-8265, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 86 276 3231; fax: +81 86 274 1028.
    • ,
  • Takaki Imamura

      Affiliations

    • Department of Neurology, Okayama Kyokuto Hospital, 567-1 Kurata, Naka-ku, Okayama 703-8265, Japan
    • ,
  • Takayoshi Shinya

      Affiliations

    • Department of PET/RI center, Okayama Kyokuto Hospital, Kurata, Naka-ku, Okayama, Japan

Received 9 September 2009 ,Revised 22 December 2009 ,Accepted 24 December 2009.

References 

  1. Miyamoto T, Miyamoto M, Inoue Y, Usui Y, Suzuki K, Hirata K. Reduced cardiac 123I-MIBG scintigraphy in idiopathic REM sleep behavior disorder. Neurology. 2006;67:2236–2238
  2. Kashihara K, Imamura T. Reduced myocardial 123I-MIBG uptake in a patient with idiopathic rapid eye movement sleep behavior disorder. Mov Disord. 2007;22:150–151
  3. Koyama S, Tachibana N, Masaoka Y, Homma I, Kawamura M. Decreased myocardial 123I-MIBG uptake and impaired facial expression recognition in a patient with REM sleep behavior disorder. Mov Disord. 2007;22:746–747
  4. Postuma RB, Lang AE, Massicotte-Marquez J, Montplaisir J. Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder. Neurology. 2006;66:845–851
  5. Schenck CH, Bundlie SR, Mahowald MW. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder. Neurology. 1996;46:388–393
  6. Orimo S, Ozawa E, Nakade S, Sugimoto T, Mizusawa H. 123I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1999;67:189–194
  7. Takatsu H, Nishida H, Matsuo H, Watanabe S, Nagashima K, Wada H, et al. Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG. J Nucl Med. 2000;41:71–77
  8. Kosaka K. Diffuse Lewy body disease. Intern Med. 1998;37:1–10
  9. Gibb WR, Lees AJ. The significance of the Lewy body in the diagnosis of idiopathic Parkinson's disease. Neuropathol Appl Neurobiol. 1989;15:27–44
  10. Uchiyama M, Isse K, Tanaka K, Yokota N, Hamamoto M, Aida S, et al. Incidental Lewy body disease in a patient with REM sleep behavior disorder. Neurology. 1995;45:709–712
  11. Braak H, Ghebremedhin E, Rüb U, Bratzke H, Del Tredici K. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res. 2004;318:121–134
  12. Braak H, de Vos RA, Bohl J, Del Tredici K. Gastric alpha-synuclein immunoreaction inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neurosci Lett. 2006;396:67–72
  13. Orimo S, Amino T, Itoh Y, Takahashi A, Kojo T, Uchihara T, et al. Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease. Acta Neuropathol (Burl). 2005;109:583–588
  14. Boeve BF, Silber HM, Saper CB, Ferman TJ, Dickson DW, Parisi JE, et al. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain. 2007;130:2770–2788
  15. Lai YY, Siegel JM. Physiological and anatomical link between Parkinson-like disease and REM sleep behavior disorder. Mol Neurobiol. 2003;27:137–151
  16. Lee PH, Kim JW, Bang OY, Joo IS, Yoon SN, Huh K. Cardiac 123I-MIBG scintigraphy in patients with essential tremor. Mov Disord. 2006;21:1235–1238
  17. Kim JS, Lee PH, Lee KS, Park JW, Kim YI, Chung YA, et al. Cardiac [123I] metaiodobenzylguanidine scintigraphy for vascular Parkinsonism. Mov Disord. 2006;21:1990–1994
  18. American Academy of Sleep Medicine . Rapid eye movement sleep behavior disorder. In: The international classification of sleep disorders; diagnostic and coding manual. 2nd ed.. Westchester: American Academy of Sleep Medicine; 2005;p. 148–151
  19. Kashihara K, Ohno M, Kawada S, Okumura Y. Reduced cardiac uptake and enhanced washout of 123I-MIBG in pure autonomic failure occurs conjointly with Parkinson's disease and dementia with Lewy bodies. J Nucl Med. 2006;47:1099–1101
  20. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology . Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. Neurology. 1996;46:1470–1472
  21. Gagnon JF, Postuma RB, Mazza S, Doyon J, Montplaisir J. Rapid-eye-movement sleep behaviour disorder and neurodegenerative diseases. Lancet Neurol. 2006;5:424–432
  22. Miyamoto T, Miyamoto M, Suzuki K, Nishibayashi M, Iwanami M, Hirata K. 123I-MIBG cardiac scintigraphy provides clues to the underlying neurodegenerative disorder in idiopathic REM sleep behavior disorder. Sleep. 2008;31:717–723
  23. Orimo S, Kanazawa T, Nakamura A, Uchihara T, Mori F, Kakita A, et al. Degeneration of cardiac sympathetic nerve can occur in multiple system atrophy. Acta Neuropathol. 2007;113:81–86
  24. Kashihara K, Yamamoto M. Myocardial 123I-MIBG scintigraphy in patients with PSP, CBD, and MSA. J Neurol. 2006;253(suppl. 3):iii35–iii40
  25. Scaglione C, Vignatelli L, Plazzi G, Marchese R, Negrotti A, Rizzo G, et al. REM sleep behaviour disorder in Parkinson's disease: a questionnaire-based study. Neurol Sci. 2005;25:316–321
  26. Olson EJ, Boeve BF, Silber MH. Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. Brain. 2000;123:331–339
  27. Orimo S, Amino T, Yokochi M, Kojo T, Uchihara T, Takahashi A, et al. Preserved cardiac sympathetic nerve accounts for normal cardiac uptake of MIBG in PARK2. Mov Disord. 2005;20:1350–1353
  28. Quattrone A, Bagnato A, Annesi G, Novellino F, Morgante L, Savettieri G, et al. Myocardial 123I-metaiodobenzylguanidine uptake in genetic Parkinson's disease. Mov Disord. 2008;23:21–27
  29. Zaccai J, Brayne C, McKeith I, Matthews F, Ince P. MRC cognitive function, ageing neuropathology study. Patterns and stages of alpha-synucleinopathy: relevance in a population-based cohort. Neurology. 2008;70:1042–1048

☆ The review of this paper was entirely handled by an Associate Editor, Eng-King Tan.

PII: S1353-8020(10)00003-9

doi: 10.1016/j.parkreldis.2009.12.010

Parkinsonism & Related Disorders
Volume 16, Issue 4 , Pages 252-255 , May 2010

Article Tools

* Image Usage & Resolution